SCHEMBL591337

SCHEMBL591337

O=S(=O)([O-])c1cccc2c(/N=N/c3ccc(/N=N/c4ccc(Nc5ccccc5)c5c(S(=O)(=O)[O-])cccc45)c4ccccc34)cccc12.[Na+].[Na+]

nearest known ligand 0.53

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRB known ✓ P10828 3/20 0.53
▸ P2RY12 known ✓ Q9H244 5/20 0.39
▸ P2RY2 known ✓ P41231 3/20 0.39
▸ P2RY4 known ✓ P51582 3/20 0.39
▸ P2RY1 known ✓ P47900 2/20 0.39
▸ P2RY6 known ✓ Q15077 2/20 0.39
▸ MEN1 O00255 2/20 0.53
▸ KMT2A Q03164 2/20 0.53
▸ SNCA P37840 2/20 0.50
▸ CHAT P28329 2/20 0.50
▸ CDK2 P24941 3/20 0.44
▸ TTR P02766 1/20 0.44
▸ FABP4 P15090 1/20 0.44
▸ CCNA2 P20248 1/20 0.44
▸ MAPK14 Q16539 1/20 0.44
▸ NR4A1 P22736 1/20 0.43
▸ ENPP2 Q13822 2/20 0.41
▸ CYP1A2 P05177 1/20 0.40
▸ PTPN1 P18031 1/20 0.38
▸ DUSP5 Q16690 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2862964 1.00 THRB (0.53) THRBMEN1KMT2ASNCACHAT
SCHEMBL29353590 1.00 THRB (0.53) THRBMEN1KMT2ASNCACHAT
SCHEMBL29356356 0.87 KMT2A (0.52) THRBMEN1KMT2ASNCACHAT
SCHEMBL2858719 0.87 KMT2A (0.52) THRBMEN1KMT2ASNCACHAT
SCHEMBL11112899 0.87 KMT2A (0.56) THRBMEN1KMT2ASNCACHAT
SCHEMBL11060395 0.86 THRB (0.50) THRBMEN1KMT2ASNCACHAT
SCHEMBL28467677 0.84 THRB (0.61) THRBMEN1KMT2ASNCACHAT
SCHEMBL29501265 0.84 MEN1 (0.69) THRBMEN1KMT2ASNCACHAT
Anazolene SCHEMBL1649427 0.81 KMT2A (0.76) THRBMEN1KMT2ASNCACHAT
Anazolene SCHEMBL23594 0.81 KMT2A (0.76) THRBMEN1KMT2ASNCACHAT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 674 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250228644-A1 METHODS FOR MARKING A TARGET LOCATION FOR A MEDICAL PROCEDURE EPHEMERAL SOLUTIONS, INC. 2025-07-17 — — US claimed
EP-4493149-A2 METHODS FOR MARKING A TARGET LOCATION FOR A MEDICAL PROCEDURE Ephemeral Solutions, Inc. (US) 2025-01-22 — — EP claimed
CN-117586497-B Preparation method of printing ink based on amino-terminated hyperbranched polyamide 江苏众立生包装科技有限公司 2024-05-03 — — CN claimed
CN-117586497-A Preparation method of printing ink based on amino-terminated hyperbranched polyamide 江苏众立生包装科技有限公司 2024-02-23 — — CN claimed
EP-4291136-A1 PARTICLES CONTAINING COLORING AGENTS AND METHODS OF USING THE SAME Ephemeral Solutions, Inc. (US) 2023-12-20 — — EP claimed
US-20230398058-A1 PARTICLES CONTAINING COLORING AGENTS AND METHODS OF USING THE SAME EPHEMERAL SOLUTIONS, INC. 2023-12-14 — — US claimed
WO-2023178213-A2 METHODS FOR MARKING A TARGET LOCATION FOR A MEDICAL PROCEDURE EPHEMERAL SOLUTIONS, INC. (US) 2023-09-21 — — WO claimed
CN-114894918-B Rapid extraction and purification method and detection method for acid dye in complex food 宁波海关技术中心 2023-07-04 — — CN claimed
WO-2022174078-A1 PARTICLES CONTAINING COLORING AGENTS AND METHODS OF USING THE SAME EPHEMERAL SOLUTIONS, INC. (US) 2022-08-18 — — WO claimed
CN-114894918-A Rapid extraction and purification method and detection method for acid dye in complex food 宁波海关技术中心 2022-08-12 — — CN claimed
US-6790411-B1 MONITORING STERILIZATION OF SURGICAL AND MEDICAL EQUIPMENT BY COLORIMETRIC ANALYSIS USING DYES 3M INNOVATIVE PROPERTIES COMPANY 2004-09-14 — — US claimed
US-20030194346-A1 Hydrogen peroxide and peracetic acid indicators and methods 3M INNOVATIVE PROPERTIES COMPANY 2003-10-16 — — US claimed
WO-2003057262-A1 HYDROGEN PEROXIDE AND PERACETIC ACID INDICATORS AND METHODS USING THE SAME 3M INNOVATIVE PROPERTIES COMPANY (US) 2003-07-17 — — WO claimed
US-6531581-B1 When incorporated into hairpin oligonucleotides these quench the fluorescence of fluorophores linked to the 5'-terminus of the oligonucleotide SEROLOGICALS, INC. 2003-03-11 — — US claimed
EP-1236040-A1 HYDROGEN PEROXIDE INDICATOR AND METHOD 3M Innovative Properties Company (US) 2002-09-04 — — EP claimed
WO-2001040792-A1 HYDROGEN PEROXIDE INDICATOR AND METHOD 3M INNOVATIVE PROPERTIES COMPANY (US) 2001-06-07 — — WO claimed
EP-1086115-A2 PURINES AND PYRIMIDINES LINKED TO A QUENCHER Intergen Company (US) 2001-03-28 — — EP claimed
US-6117986-A QUENCHING FLUORESCENCE INTERGEN COMPANY, L.P. (US) 2000-09-12 — — US claimed
WO-1999064431-A2 PURINES AND PYRIMIDINES LINKED TO A QUENCHER INTERGEN COMPANY (US) 1999-12-16 — — WO claimed
EP-0583133-B1 Ink jet printing method CANON KK (JP) 1998-11-11 — — EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230398058-A1 PARTICLES CONTAINING COLORING AGENTS AND METHODS OF USING THE SAME LDHA, CUTA, LIPA THRB 3072/4885P2RY12 4372/4885P2RY2 4528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback